Singapore markets closed
Straits Times Index
3,332.80 -10.55 (-0.32%) Nikkei
39,583.08 +241.54 (+0.61%) Hang Seng
17,718.61 +2.14 (+0.01%) FTSE 100
8,164.12 -15.56 (-0.19%) Bitcoin USD
60,904.30 -676.22 (-1.10%) CMC Crypto 200
1,270.61 -13.22 (-1.03%)
Shenzhen Kangtai Biological Products Co., Ltd. (300601.SZ)
Shenzhen - Shenzhen Delayed price. Currency in CNY
Add to watchlist
At close: 03:04PM CST
Currency in CNY
Valuation measures4
| Market cap (intra-day) | 17.59B |
| Enterprise value | 19.23B |
| Trailing P/E | 24.61 |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 5.46 |
| Price/book (mrq) | 1.83 |
| Enterprise value/revenue | 6.04 |
| Enterprise value/EBITDA | 21.78 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.75 |
| 52-week change 3 | -37.97% |
| S&P500 52-week change 3 | 23.20% |
| 52-week high 3 | 34.18 |
| 52-week low 3 | 15.58 |
| 50-day moving average 3 | 18.78 |
| 200-day moving average 3 | 24.74 |
Share statistics
| Avg vol (3-month) 3 | 9.61M |
| Avg vol (10-day) 3 | 8.99M |
| Shares outstanding 5 | 1.12B |
| Implied shares outstanding 6 | 1.12B |
| Float 8 | 578.42M |
| % held by insiders 1 | 48.55% |
| % held by institutions 1 | 9.24% |
| Shares short 4 | N/A |
| Short ratio 4 | N/A |
| Short % of float 4 | N/A |
| Short % of shares outstanding 4 | N/A |
| Shares short (prior month ) 4 | N/A |
Dividends & splits
| Forward annual dividend rate 4 | 0.38 |
| Forward annual dividend yield 4 | 2.41% |
| Trailing annual dividend rate 3 | 0.38 |
| Trailing annual dividend yield 3 | 2.41% |
| 5-year average dividend yield 4 | 0.78 |
| Payout ratio 4 | 28.13% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | 14 Jun 2024 |
| Last split factor 2 | 1.6:1 |
| Last split date 3 | 02 Jun 2022 |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | 22.32% |
| Operating margin (ttm) | 5.95% |
Management effectiveness
| Return on assets (ttm) | 2.41% |
| Return on equity (ttm) | 7.59% |
Income statement
| Revenue (ttm) | 3.18B |
| Revenue per share (ttm) | 2.88 |
| Quarterly revenue growth (yoy) | -39.60% |
| Gross profit (ttm) | N/A |
| EBITDA | 1.1B |
| Net income avi to common (ttm) | 709.91M |
| Diluted EPS (ttm) | 0.64 |
| Quarterly earnings growth (yoy) | -73.70% |
Balance sheet
| Total cash (mrq) | 996.96M |
| Total cash per share (mrq) | 0.89 |
| Total debt (mrq) | 2.63B |
| Total debt/equity (mrq) | 27.36% |
| Current ratio (mrq) | 1.82 |
| Book value per share (mrq) | 8.61 |
Cash flow statement
| Operating cash flow (ttm) | 828.33M |
| Levered free cash flow (ttm) | 432.21M |
© 2024 Yahoo. All rights reserved.